| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 671.01 | 457.37 | 86.32 | 0.35 |
| Cash Equivalents | 11.89 | - | 0.95 | 0.04 |
| Other Liabilities Total | 0.99 | 0.09 | - | - |
| Long Term Debt | 0.26 | 0.26 | 0.00 | 0.00 |
| Common Stock Total | 65.45 | 63.80 | 53.50 | 0.17 |
| Other Equity Total | 1.47 | -0.22 | - | - |
| Other Current Assets Total | 84.49 | 0.40 | 2.06 | 0.04 |
| Total Assets | 671.01 | 457.37 | 86.32 | 0.35 |
| Current Portof LT Debt/ Capital Leases | 8.12 | 8.03 | 0.43 | - |
| Total Equity | 384.39 | 337.52 | 81.11 | -0.27 |
| Long Term Investments | 168.66 | 10.77 | 1.21 | - |
| Retained Earnings( Accumulated Deficit) | 317.47 | 33.13 | 27.61 | -0.44 |
| Total Common Shares Outstanding | 65.45 | 63.80 | 53.50 | 0.17 |
| Tangible Book Valueper Share Common Eq | 5.79 | 5.21 | 1.47 | -1.55 |
| Goodwill Net | 5.28 | 5.28 | 2.22 | - |
| Total Liabilities | 286.63 | 119.85 | 5.21 | 0.62 |
| Total Debt | 107.08 | 85.37 | 1.68 | 0.57 |
| Short Term Investments | 19.66 | 147.09 | 40.05 | 0.01 |
| Cashand Short Term Investments | 31.55 | 251.36 | 41.00 | 0.04 |
| Total Receivables Net | 288.89 | 104.16 | 22.87 | 0.17 |
| Notes Payable/ Short Term Debt | 72.10 | 60.14 | 0.00 | 0.57 |
| Deferred Income Tax | 0.00 | 0.39 | 0.12 | - |
| Accounts Receivable- Trade Net | 288.80 | 76.18 | 22.87 | 0.17 |
| Property/ Plant/ Equipment Total- Net | 29.33 | 19.72 | 12.49 | - |
| Minority Interest | 0.76 | 0.34 | - | - |
| Total Current Liabilities | 258.03 | 101.82 | 3.83 | 0.62 |
| Total Inventory | 12.66 | 9.16 | 4.48 | - |
| Accounts Payable | 102.60 | 20.65 | 2.16 | 0.01 |
| Other Currentliabilities Total | 75.20 | 12.71 | 1.25 | 0.03 |
| Total Long Term Debt | 26.86 | 17.21 | 1.25 | 0.00 |
| Other Long Term Assets Total | 50.16 | 17.73 | 0.00 | 0.11 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 417.59 | 365.29 | 70.41 | 0.25 |
| Capital Lease Obligations | 26.59 | 16.94 | 1.25 | - |
| Accumulated Depreciation Total | - | -2.84 | - | - |
| Accrued Expenses | - | 0.29 | - | - |
| Prepaid Expenses | - | 0.21 | - | - |
| Additional Paid- In Capital | - | 240.82 | - | - |
| Cash | - | 104.26 | - | - |
| Property/ Plant/ Equipment Total- Gross | - | 21.44 | - | - |
| Note Receivable- Long Term | - | 38.59 | - | - |
Fischer Medical Ventures Dividend Fischer Medical Ventures Bonus Fischer Medical Ventures News Fischer Medical Ventures AGM Fischer Medical Ventures Rights Fischer Medical Ventures Splits Fischer Medical Ventures Board Meetings Fischer Medical Ventures Key Metrics Fischer Medical Ventures Shareholdings Fischer Medical Ventures Profit Loss Fischer Medical Ventures Cashflow Fischer Medical Ventures Q1 Results Fischer Medical Ventures Q2 Results Fischer Medical Ventures Q3 Results Fischer Medical Ventures Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.